BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30815771)

  • 41. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
    Zhao L; Zhang Y
    Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression].
    Wang Y; Lu Z; Li Y; Ji D; Zhang P; Liu Q; Yao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1076-9. PubMed ID: 25270212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC).
    Gao B; Gao K; Li L; Huang Z; Lin L
    Biomed Pharmacother; 2014 Mar; 68(2):143-8. PubMed ID: 24183204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [miR-455 Inhibits HepG2 Cell Proliferation and Promotes Apoptosis by Targeting RhoC].
    Xie SL; Wang M; Du XH; Zhao ZW; Lv GY
    Mol Biol (Mosk); 2020; 54(1):69-77. PubMed ID: 32163390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma.
    Cheng B; Ding F; Huang CY; Xiao H; Fei FY; Li J
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):137-145. PubMed ID: 30657555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-9 exerts antitumor effects on hepatocellular carcinoma progression by targeting HMGA2.
    Xu X; Zou H; Luo L; Wang X; Wang G
    FEBS Open Bio; 2019 Oct; 9(10):1784-1797. PubMed ID: 31408273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155.
    Zhang Y; Li X; Zhang Y; Wang L; Xu J; Du J; Guan Y
    Ann Hepatol; 2019; 18(3):494-500. PubMed ID: 31036495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-216b is downregulated in hepatocellular carcinoma and inhibits HepG2 cell growth by targeting Forkhead box protein M1.
    Zheng WW; Zhou J; Zhang CH; Liu XS
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2541-50. PubMed ID: 27383303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1.
    Hu S; Tao R; Wang S; Wang C; Zhao X; Zhao H; Li L; Zhu S; He Y; Jiang X; Gao Y
    Tumour Biol; 2015 Jul; 36(7):5467-72. PubMed ID: 25687183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-490-5p inhibits the stemness of hepatocellular carcinoma cells by targeting ECT2.
    Yu Y; Cai O; Wu P; Tan S
    J Cell Biochem; 2019 Jan; 120(1):967-976. PubMed ID: 30206962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma.
    Liu H; Li W; Chen C; Pei Y; Long X
    Tumour Biol; 2015 Aug; 36(8):6313-9. PubMed ID: 25804796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Gao F; Sun X; Wang L; Tang S; Yan C
    Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. microRNA-23b suppresses epithelial-mesenchymal transition (EMT) and metastasis in hepatocellular carcinoma via targeting Pyk2.
    Cao J; Liu J; Long J; Fu J; Huang L; Li J; Liu C; Zhang X; Yan Y
    Biomed Pharmacother; 2017 May; 89():642-650. PubMed ID: 28262617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-876-5p acts as an inhibitor in hepatocellular carcinoma progression by targeting DNMT3A.
    Wang Y; Xie Y; Li X; Lin J; Zhang S; Li Z; Huo L; Gong R
    Pathol Res Pract; 2018 Jul; 214(7):1024-1030. PubMed ID: 29724530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.
    Du X; Fan W; Chen Y
    Gene; 2018 May; 657():30-38. PubMed ID: 29505836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-107 promotes hepatocellular carcinoma cell proliferation by targeting Axin2.
    Zhang JJ; Wang CY; Hua L; Yao KH; Chen JT; Hu JH
    Int J Clin Exp Pathol; 2015; 8(5):5168-74. PubMed ID: 26191213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma.
    Ding W; Tan H; Zhao C; Li X; Li Z; Jiang C; Zhang Y; Wang L
    Tumour Biol; 2016 May; 37(5):6255-60. PubMed ID: 26615424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway.
    Drakaki A; Hatziapostolou M; Polytarchou C; Vorvis C; Poultsides GA; Souglakos J; Georgoulias V; Iliopoulos D
    BMC Cancer; 2015 Jul; 15():542. PubMed ID: 26206264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.